VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 150 filers reported holding VENTYX BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $19,131 | -69.4% | 8,282 | -27.3% | 0.00% | -62.5% |
| Q1 2024 | $62,618 | +271.1% | 11,385 | +66.6% | 0.01% | +166.7% |
| Q4 2023 | $16,875 | -67.7% | 6,832 | +353.7% | 0.00% | -80.0% |
| Q3 2023 | $52,303 | +107.9% | 1,506 | +96.3% | 0.02% | +87.5% |
| Q2 2023 | $25,158 | -2.1% | 767 | 0.0% | 0.01% | -11.1% |
| Q1 2023 | $25,695 | +36.3% | 767 | +33.4% | 0.01% | +12.5% |
| Q4 2022 | $18,854 | – | 575 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 412,225 | $952,240 | 1.81% |
| Octagon Capital Advisors LP | 2,391,114 | $5,523,473 | 0.87% |
| TANG CAPITAL MANAGEMENT LLC | 3,100,000 | $7,161,000 | 0.73% |
| Opaleye Management Inc. | 1,190,000 | $2,748,900 | 0.63% |
| Sio Capital Management, LLC | 778,924 | $1,799,314 | 0.49% |
| Parkman Healthcare Partners LLC | 1,160,022 | $2,679,651 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,012,749 | $2,339,450 | 0.32% |
| Redmile Group, LLC | 2,164,126 | $4,999,131 | 0.30% |
| WEXFORD CAPITAL LP | 449,046 | $1,037,296 | 0.26% |
| Vestal Point Capital, LP | 1,315,000 | $3,037,650 | 0.23% |